MedNews

You are here: Home / FDA News & Alerts / Final FDA Guidance Issued on Evaluation and Labeling of Abuse-deterrent Opioids

Final FDA Guidance Issued on Evaluation and Labeling of Abuse-deterrent Opioids

By Leave a Comment

The U.S. Food and Drug Administration today issued a final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties.O

Source:: FDA News



Leave a Reply

Your email address will not be published. Required fields are marked *